Sonoma Pharmaceuticals (SNOA) News Today $2.99 +0.15 (+5.28%) (As of 02:00 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care HydrogelNovember 12, 2024 | finanznachrichten.deFDA grants Sonoma 510(k) approval for Microdacyn HydrogelNovember 12, 2024 | markets.businessinsider.comSonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor ConferencesOctober 22, 2024 | stockhouse.comSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200 Day Moving Average - Should You Sell?October 11, 2024 | marketbeat.comSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comSonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above Two Hundred Day Moving Average of $0.33Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average of $0.33September 20, 2024 | marketbeat.comShort Interest in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Drops By 65.4%Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA - Get Free Report) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 130,300 shares, a decline of 65.4% from the August 15th total of 376,200 shares. Currently, 13.0% of the shares of the company are short sold. Based on an average trading volume of 192,400 shares, the days-to-cover ratio is currently 0.7 days.September 12, 2024 | marketbeat.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product LineSeptember 11, 2024 | finanznachrichten.deSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above 200 Day Moving Average of $0.23Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200 Day Moving Average of $0.23August 31, 2024 | marketbeat.comSonoma Pharmaceuticals Inc (O8Z3.MU)August 30, 2024 | uk.finance.yahoo.comWhy Sonoma Pharmaceuticals (SNOA) Stock Is MovingAugust 28, 2024 | benzinga.comSonoma Pharmaceuticals First Quarter 2025 Earnings: Misses ExpectationsAugust 12, 2024 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial ResultsAugust 9, 2024 | finanznachrichten.deSNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025August 9, 2024 | investorplace.comSonoma Pharmaceuticals, Inc. (SNOA)July 20, 2024 | finance.yahoo.comSNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024June 17, 2024 | investorplace.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement StoresMay 9, 2024 | finanznachrichten.deSonoma Pharmaceuticals Inc.April 30, 2024 | money.usnews.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesApril 9, 2024 | finanznachrichten.deSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor ConferencesMarch 28, 2024 | finanznachrichten.deSonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 10, 2024 | finance.yahoo.comSonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial ResultsFebruary 8, 2024 | finance.yahoo.comSonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily UseJanuary 23, 2024 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsNovember 13, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsNovember 13, 2023 | finance.yahoo.comSonoma Pharmaceuticals Inc SNOANovember 11, 2023 | morningstar.comSonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall ConferenceNovember 3, 2023 | finance.yahoo.comUS Stocks Mixed; Bristol Myers Posts Upbeat EarningsOctober 26, 2023 | benzinga.comCrude Oil Down 2.5%; Mastercard Posts Upbeat EarningsOctober 26, 2023 | markets.businessinsider.comDow Dips Over 100 Points; US GDP Growth Tops ExpectationsOctober 26, 2023 | benzinga.comSonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common StockOctober 26, 2023 | finance.yahoo.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62%October 24, 2023 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.62%October 24, 2023 | msn.commacOS SonomaSeptember 28, 2023 | macrumors.comNational Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn AdvancedAugust 15, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial ResultsAugust 10, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial ResultsAugust 10, 2023 | finance.yahoo.comSonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory BoardAugust 3, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsJune 22, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsJune 22, 2023 | finance.yahoo.comSonoma Pharmaceuticals Shares Soar 44% After Introducing New ProductJune 9, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European UnionJune 8, 2023 | finanznachrichten.deSonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European UnionJune 8, 2023 | finance.yahoo.comWilliams-Sonoma Could Be Headed for More TroubleMay 21, 2023 | thestreet.com8-K: Sonoma Pharmaceuticals, Inc.May 11, 2023 | marketwatch.comBenign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share PriceApril 19, 2023 | finance.yahoo.comGetting Around SonomaApril 14, 2023 | travel.usnews.comTrack Covid-19 in Sonoma County, CaliforniaApril 12, 2023 | nytimes.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot CareApril 11, 2023 | finanznachrichten.deSonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot CareApril 11, 2023 | finance.yahoo.com Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! SNOA Media Mentions By Week SNOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNOA News Sentiment▼0.000.47▲Average Medical News Sentiment SNOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNOA Articles This Week▼00▲SNOA Articles Average Week Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aprea Therapeutics News Today TherapeuticsMD News Today Akari Therapeutics News Today Mannatech News Today IN8bio News Today Minerva Neurosciences News Today NRx Pharmaceuticals News Today Kazia Therapeutics News Today AIM ImmunoTech News Today Sol-Gel Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNOA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
